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Abstract: Viologen-SWCNT hybrids are synthesized by aryl-diazonium chemistry in the 
presence of isoamyl nitrite followed by condensation reaction of the resulting HOOC-Phe-
SWCNT with 1-(3-aminoethyl)-4,4’-bipyridinium bromine and N-alkylation with 2-
bromoethylamine. The V-Phe-SWCNT hybrids were characterized by using different 
spectroscopic techniques (FT-IR, Raman, UV-vis), TGA and Kaiser test. Viologen-
SWCNTs were used for the preparation of an electrochemical immunosensor for  the 
determination of the transforming growth factor β1 (TGF-β1) cytokine considered as a 
reliable biomarker in several human diseases. The methodology involved preparation of V-
Phe-SWCNT(-HRP)-anti-TGF conjugates by covalent linkage of HRP and anti-TGF onto 
V-Phe-SWCNT hybrids. Biotinylated anti-TGF antibodies were immobilized onto 4-
carboxyphenyl-functionalized SPCEs modified with streptavidin and a sandwich type 
 2 
immunoassay was implemented for TGF-β1 with signal amplification using V-Phe-
SWCNT(-HRP)-anti-TGF conjugates as carrier tags. The analytical characteristics 
exhibited by the as prepared immunosensor (range of linearity between 2.5 and 1000 pg 
mL
-1
 TGF-β1; detection  limit of 0.95 pg mL-1) improve notably those reported with other 
previous immunosensors or ELISA kits. A great selectivity against other proteins was also 
found. The prepared immunosensor was validated by determining TGF-β1 in real saliva 
samples. Minimal sample treatment was required and the obtained results were in excellent 
agreement with those obtained by using a commercial ELISA kit. 
Keywords: viologen, transforming growth factor β1, cytokine, saliva, electrochemical 
immunosensor 
 
1. Introduction 
Viologens are 4,4´-bipyridine derivatives which exhibit reversible electrochemical 
responses at negative potentials corresponding to their three possible oxidation states, 
V
2+↔V+∙↔ V0. The first reaction constitutes the basis for application of viologens as 
electron acceptors and electron transfer mediators to various proteins [Chen et al., 2009]. 
The reversible redox behavior promotes the electron exchange between electrodes and 
proteins with the subsequent decrease in the ohmic overpotential [Lee et al., 2016]. Taking 
advantage of this behavior, various electrochemical biosensors based on the use of 
viologens have been described. However, due to the solubility of viologen cations in 
aqueous solution and their high toxicity, immobilization on electrode surfaces using 
different strategies and materials is usually performed [Lee et al., 2016] [Ghica et al., 
2005].  An illustrative example of strategy not involving physical entrapment of viologen is 
the modification of a GCE based on the amino radical oxidation with subsequent formation 
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of a carbon-nitrogen linkage on the electrode for the preparation of a hydrogen peroxide 
biosensor with horseradish peroxidase and gold nanoparticles [Jia et al., 2008].  .    Another 
interesting approach relies on modification of a gold electrode with a self-assembled 
monolayer of thiol-functionalized viologen which was used to design a biosensor involving 
direct electron transfer of hemoglobin for the detection of H2O2 [Kafi et al., 2007]. 
Configurations using viologens have been implemented in the development of 
electrochemical immunosensors. A label-free design for the detection of α-fetoprotein was 
reported using gold nanoparticles functionalized by covalent surface capping with 1,1′-bis-
(2-mercapto)-4,4′-bipyridinium dibromide [Liang et al., 2009]. A platform for the 
construction of multi-array electrochemical immunosensors was prepared by 
immobilization of biotinylated viologen on modified polypyrrole-streptavidin films. In this 
strategy, the change in the electrochemical response of the redox molecule corresponding to 
the two electrons reduction of di-cationic to neutral viologen was monitored after the 
antibody-antigen interaction [Miodek et al., 2016]. The direct impedimetric detection of an 
anti-cholera toxin antibody was performed by using electropolymerized biotinylated 
poly(pyrrole-viologen) film as scaffold for the development of reagentless immunosensors 
[Gondram et al., 2010]. The selective detection of α-fetoprotein (AFP) was performed by 
using an electrochemical immunosensor prepared by covalent immobilization of 
polyamidoamine (PAMAM) dendrimer-encapsulated AuNPs on a gold electrode followed 
by sequential immobilization of ethyleneamine-viologen as the redox marker and AFP 
antibody [Kavosi et al., 2014]. Regarding DNA sensors, an interesting strategy involved a 
conjugate integrating an anthracene chromophore and a viologen moiety in the same 
molecular skeleton for discrimination between non-hybridized and hybridized surface-
immobilized DNA [Conoci et al., 2014]. 
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Viologens have been immobilized on materials such as graphene oxide [Park et al., 2012], 
conductive polymers [Gadgil et al., 2013], dendrimers [Kavosi et al., 2014] and carbon 
nanotubes (CNTs). Immobilization methods on CNTs included  drop casting  of viologen 
solution  and electrochemical treatment by cyclic voltammetry [Swetha et al., 2012] [Lee et 
al., 2016], preparation of multilayers   assembled through electrostatic interactions [Wang 
et al., 2008], and formation of  composites  [Wang et al., 2009]. Few examples of covalent 
attachment of viologens on CNTs have been described so far. Synthesis of an 
asymmetrically substituted viologen covalently anchored to SWCNTs through an ester 
linkage by reacting chlorinated purified SWCNTs with N-methyl-N´-(6-hydroxyhexyl)-
4,4´-bipyridine was reported [Alvaro et al., 2005]. More recently, Liu et al. [Liu et al., 
2013] linked covalently an electroactive organic electrolyte of viologen on MWCNTs 
through a diazonium coupling process to form layer-by-layer (LBL) multi-layers with 
poly(sodium-p-styrenesulfonate) at interfaces. A couple of redox waves in the potential 
range of -0.3 – -0.7 V vs. Ag/AgCl, corresponding to the electron transfer process of 
MWCNT-PhV
2+
 ↔ MWCNT-PhV+• was observed. 
Transforming growth factor β1 (TGF-β1) is a cytokine belonging to the structurally related 
group of multifunctional TGF-βs which regulates a variety of biological processes. In 
particular, TGF-β1 is involved in immune and inflammatory responses [Tsapenko et al., 
2013] and is considered as a good biomarker of bladder carcinoma, liver fibrosis, or renal 
diseases. Normal levels of this protein are in the 0.1 - 25 ng/mL range in plasma of healthy 
individuals [Grainger et al., 2000]. However, noticeable increases in circulating TGF-β1 
can be found in patients suffering various types of cancer [Wickenhauser et al., 1995] or 
autoimmune disorders [Pfeiffer et al., 1996]. Methods for the determination of this cytokine 
comprise immunoassays with ELISA kits involving sandwich type configurations and 
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peroxidase-labeled or biotinylated immunoreagents. Regarding electrochemical 
immunosensors, very few methods can be found in the literature. An impedimetric design 
for the determination of TGF-β1 in serum was reported involving the preparation of a self-
assembled monolayer of polyethylene glycol coated onto interdigitated electrodes. Covalent 
immobilization of antibodies allowed TGF-β1 determination in a linear range between 1 
and 1000 ng/mL with a detection limit of 0.570 ng/mL [Yao et al., 2016]. CNTs 
functionalized by click chemistry were used as scaffolds for the preparation of an 
electrochemical immunosensor for TGF-β1 determination in serum [Sánchez-Tirado et al., 
2016]. MWCNTs were functionalized by means of copper(I) catalyzed azide–alkyne 
cycloaddition followed by conjugation of an alkyne-functionalized IgG and assembling 
IgG-alkyne–azide–MWCNT conjugates for immobilization of antibodies. Once the target 
cytokine was sandwiched with biotinylated anti-TGF labeled with poly(HRP-Strept) 
conjugates, the affinity reaction was monitored amperometrically at −0.20 V using the 
hydroquinone/H2O2 system. The calibration plot for TGF-β1 exhibited a range of linearity 
extending between 5 and 200 pg/mL, and the limit of detection was 1.3 pg/mL. Recently, 
our group also developed an amperometric immunosensor for TGF-β1 using carboxylic 
acid-functionalized magnetic microparticles supported onto screen-printed carbon 
electrodes (SPCEs) to immobilize covalently the specific antibodies by means of Mix&Go 
polymer. A sandwich-type scheme was prepared with anti-TGF-biotin and conjugation with 
poly(HRP-Strept) for signal amplification. Amperometric measurements as described 
above provided a calibration plot with a linear range between 15 and 3000 pg/mL and a 
LOD value of 10 pg/mL. This configuration was validated by analyzing spiked urine at 
different TGF-β1 pg/mL concentration levels [Sánchez-Tirado et al., 2017]. Moreover, an 
aptasensor for TGF-β1 involving aptamer-modified Au electrodes integrated with 
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microfluidics was reported. Thiolated aptamers labeled with methylene blue were self-
assembled on gold surfaces. The linear range covered up to 250 ng/mL with a detection 
limit of 1ng/mL. This device was used to monitor TGF-β1 release from hepatic cells 
[Matharu et al., 2014]. 
This work reports a novel method for the preparation of viologen-SWCNT hybrids (V-Phe-
SWCNTs) through aryl-diazonium chemistry in the presence of isoamyl nitrite followed by 
simple condensation reaction of the resulting HOOC-Phe-SWCNT with 1-(3-aminoethyl)-
4,4’-bipyridinium bromine and N-alkylation with 2-bromoethylamine. The as prepared V-
Phe-SWCNTs are used as carrier tags for signal amplification in the construction of an 
amperometric immunosensor for TGF-β1. Anti-TGF antibodies and HRP were 
immobilized on the synthesized V-Phe-SWCNT hybrids, and the target cytokine was 
sandwiched with V-Phe-SWCNT(-HRP)-anti-TGF conjugates and biotinylated antibodies 
immobilized onto SPCEs modified with streptavidin. The implementation of a sandwich 
type immunoassay allowed improved analytical characteristics to be obtained in terms of 
wider linear dynamic range of response and lower detection limit than those reported with 
other immunosensors and ELISA kits. In addition, a great selectivity against other proteins 
and ascorbic and uric acid was also found. The developed immunosensor was validated by 
determining TGF-β1 in real saliva samples with minimal sample treatment, and providing 
results in excellent agreement with those obtained by using a commercial ELISA kit. 
 
 
 
2. Experimental 
2.1. Reagents and solutions.  
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All commercial solvents and reagents used for the synthesis of V-Phe-SWCNTs were 
employed without further purification. HiPco SWCNTs were purchased from NanoIntegris 
(www.nanointegris.com), with a diameter between 0.8-1.2 nm and length 100-1000 nm. 
Chicken biotinylated antibody (anti-TGF-Biotin), human TGF–β1, and mouse antibody 
(anti-TGF) were from R&D Systems. These reagents were included in the Duo Sets ELISA 
Development System (DY240-05). Horseradish peroxidase (HRP), streptavidin, hydrogen 
peroxide, hydroquinone, and terephthalic acid were from Sigma. 1–ethyl–3–(3–
dimethylaminopropyl)carbodiimide(EDC),N–hydroxy-sulfosuccinimide (NHSS), and 4-
aminobenzoic acid (4-ABA) were from Across. Sodium nitrite from Panreac was also used. 
Anti-TGF-Biotin solutions were prepared in Reagent Diluent 1 from Duoset
®
 Ancillary 
Reagent Kit 1 (R&D Systems, DY007). Anti-TGF solutions were prepared in 0.1 M 
phosphate buffer solution of pH 7.4. This buffer solution was also used for preparing 0.5 
mM solutions of D-biotin (Gerbu) used as blocking agent. 25 mM MES buffer solution of 
pH 5.0 prepared from 2–(N–morpholine) ethanosulfonic acid (Gerbu) was also used. 
Adiponectin (APN), tumor necrosis factor alfa (TNF–α) and interleukin 1 beta (IL–1) 
from R&D Systems, cortisol and human inmunoglobulin G (IgG) from Sigma,interleukin 6 
(IL–6) and interleukin 8 (IL–8) from Abcam, and bovine serum albumin (BSA, Gerbu) 
were tested as potential interfering compounds. Deionized water was obtained from a 
Millipore Milli-Q purification system (18.2M Ω cm at 25 °C). 
 
2.2. Apparatus and electrodes.  
Nuclear magnetic resonance 1H and 13C were recorded using Bruker Innova 400 MHz. 
Absorption spectra (UV-vis) were performed on Shimadzu UV 3600 spectrophotometer. 
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The thermogravimetric analysis was performed on a Mettler Toledo TGA/DSC Linea 
Excellent under inert atmosphere of nitrogen with a rate of 10°C/min, and the weight 
changes were recorded as a function of temperature. Raman measurements were carried out 
with a Renishaw inVia Reflex Confocal Raman Microscope at room temperature using 
laser excitation of 785 nm. Measurements were taken with 10 s of exposure times at 
varying numbers of accumulations. The laser spot was focused on the sample surface using 
a long working distance 100x objective. Raman spectra were collected on numerous spots 
on the sample and recorded with a Peltier cooled CCD camera. The sample was measured 
on glass without any sample preparation. The intensity ratio ID/IG was obtained by taking 
the peak intensities following any baseline corrections. FTIR spectrum were obtained on 
Avatar 370 Thermo Nicolet spectrophotometer using KBr pellets. 
The following instruments were utilized for the preparation and functioning of the 
immunosensor: An INBEA potentiostat provided with the Ib Graph software was used for 
the amperometric measurements; electrochemical impedance spectroscopy was carried out 
with a μAutolab type III potentiostat (Ecochemie) controlled by FRA2 software. Screen-
printed carbon electrodes (SPCEs, 110 DRP, ϕ 4 mm) purchased from DropSens (Oviedo, 
Spain) were used as working electrodes. These electrodes were provided with a silver 
pseudo-reference electrode and a carbon counter electrode. A Crison Basic 20+ pHmeter, 
an Elmasonic S-60 ultrasonic bath (Elma), an MPW-65R centrifuge from MPW Med. 
Instruments, a Vortex homogenizer and a magnetic stirrer, both from Velp Scientifica, were 
also employed. 
 
 
2.3. Procedures 
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2.3.1. Functionalization of SWCNT.  
The preparation of viologen-SWCNT hybrid (V-Phe-SWCNT) was performed in three 
steps: 
1.  Synthesis of 1-(3-aminoethyl)-4,4’-bipyridinium bromine: A solution of 4,4’-bipyridine 
(500 mg, 3.2 mmol) and 2-bromoethylamine (71.4 mg, 0.32 mmol) in acetonitrile (10 mL) 
was refluxed for 1.5 h. After cooling, the precipitate was filtered and re-dissolved in hot 
DMF to remove the di-alkylated salt by filtration. In order to get the mono-alkylated 
product as a white solid, diethyl ether was added. Yield: 59 %. 
1
H NMR (400 MHz, D2O); 
δ: 9.08 (d, J = 6.3 Hz, 2H), 8.80 (d, 2H), 8.52 (d, J = 6.3 Hz, 2H), 7.95 (d, J = 6.3 Hz, 2H), 
5.06 (t, J = 6.5 Hz, 2H), 3.78 (t, J = 6.5 Hz, 2H).
13
C NMR (100 MHz, D2O); δ: 155.11, 
149.91, 145.35, 142.31, 126.62, 122.54, 57.63, 39.11. 
2. Synthesis of HOOC-SWCNT: A suspension of pristine-SWCNT (20 mg) in N-methyl-2-
pyrrolidone (40 mL) was sonicated for 10 min, then 4-aminobenzoic acid (457 mg, 3.33 
mmol, and isoamyl nitrite (0.54 mL, 3.98 mmol) were added. The mixture was stirred 
under argon atmosphere at 70°C for 24 h. After cooling, the crude was filtered through 
PTFE membrane (Millipore 0.1 µm pore) and washed subsequently with NMP, MeOH and 
CH2Cl2, until the filtrate was clear, to obtain the carbon-based material as a black solid (23 
mg). 
3. Synthesis of viologen-SWCNT hybrid (V-Phe-SWCNT): SWCNT-Phe-COOH (8 mg) 
were dispersed in DMF anhydrous (20 mL) N,N'-dicyclohexylcarbodiimide (DCC) (21.9 
mg, 0.11 mmol), hydroxybenzotriazole (HOBt) (14.4 mg, 0.11 mmol), and 1-(3-
aminoethyl)-4,4’-bipyridinium bromine (16 mg, 0.08 mmol) were added to the mixture 
under argon atmosphere. The suspension was sonicated for 10 minutes and heated at 60°C 
for 3 days. The solid was separated by filtration through a PFTE membrane (Millipore 0.1 
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µm pore) and washed several times with hot DMF, MeOH and CH2Cl2. Thereafter, the 
solid was re-dissolved in DMF, and 2-bromoethylamine (16 mg, 0.08 mmol) was added. 
The reaction mixture was heated at 120°C for 24 h, and then filtered on a PFTE membrane 
(Millipore 0.1 µm pore). Finally, the solid was washed with DMF, MeOH and CH2Cl2 to 
get the V-Phe-SWCNTs (9.4 mg). 
2.3.2. Preparation of V-Phe-SWCNT(-HRP)-anti-TGF conjugate.  
To obtain 100 µL of V-Phe-SWCNT(-HRP)-anti-TGF, 50 µL of a 200 mM EDC/NHSS 
solution prepared in 25 mM MES of pH 5.0 were mixed with 50 µL of 4 mg mL
-1
 
terephthalic acid, and 100 µL of each 40 µg mL
-1
 HRP, 4 µg mL
-1
 anti–TGF. and 0.5 mg 
mL
-1 
aqueous V–SWCNT suspension. The mixture was incubated under magnetic stirring 
in the dark for 3 h. Once centrifuged at 8
o
C and 14,000 rpm for 10 min, supernatant was 
retired and two washing steps with 500 µL of 0.1 M PBS of pH 7.4 were performed. 
Finally, the  obtained  conjugate was suspended in 100 µL of PBS. 
2.3.3. Preparation of V-Phe-SWCNT(-HRP)-anti-TGF-TGF-β1-anti-TGF-Biotin-
Strept/ SPCEs.  
In a first step, SPCEs were modified by grafting of a 4-ABA diazonium salt on the 
electrode surface. In order to do that, 20 mg of 4-ABA were dissolved in 2 mL of 1 M HCl 
and cooled with ice. Then, the diazonium salt was prepared by adding 2 mM NaNO2 
aqueous solution dropwise to this solution (38 µL for each 200 µL) with constant stirring. 
Next, 40 µL of the resulting solution was casted onto the SPCE and ten successive cyclic 
voltammetric scans between 0.0 and −1.0 V (ν = 200 mV s-1) were carried out. The 
modified electrodes were washed thoroughly with water and dried at room temperature. 
Dried ABA-g-SPCEs were activated by dropping 5 µL of EDC/NHSS (0.1 M each) 
prepared in MES buffer solution of pH 5.0 and allowed 30 min to stand. After rinsing with 
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water, 5 µL of a 200 µg mL
−1
 streptavidin solution prepared in MES buffer of pH 5.0 were 
added and left to react for 1 h. Next, the electrodes were rinsed with water and dried. 
Immobilization of biotinylated antibody was further performed by adding 5 µL of a 7.5 µg 
mL
-1
 anti-TGF-Biotin prepared in  Reagent Diluent 1 from Duoset
®
 Ancillary Reagent Kit 
1 (R&D Systems, DY007) on the modified electrode and left to stand for 60 min. Then, a 
blocking step was made by adding 5 µL of a 0.5 mg mL
-1
 biotin and left to incubate 30 min. 
Thereafter, 5 μL of standard TGF–β1 solutions or the samples were placed onto the 
electrode surface and incubated for 60 min. After washing with water and drying, 5 μL of 
V–SWCNT(-HRP)-anti-TGF were dropped onto the electrode and incubated for 60 min. 
Finally, the immunosensor was washed again and maintained with a drop of a 0.05 M PBS 
solution of pH 6.0 until the measurements were made. 
2.3.4. Amperometric measurements.  
Amperometric measurements were performed by adding 45 μL of 0.5 M PBS of pH 6.0 to 
the immunosensor surface and applying a potential of -300 mV. Once the background 
current was stabilized, (around 100 s), 5 μL of 50 mM H2O2 were added and allowed 
standing for 200 s to complete the enzyme reaction. 
2.3.5. Analysis of saliva.  
Saliva samples were obtained from volunteers and collected using a Salivette® collection 
device (Sarstedt). Briefly, once rinsed the mouth thoroughly with water, a cotton swab was 
inserted into the mouth and chewed for 1 min. Then, the swap saturated with saliva was 
inserted into the vial, sealed with the cap and centrifuged for 10 min at 3000 rpm. The 
determination was performed immediately by applying the procedure described above to 5 
μL of undiluted saliva and interpolation of the amperometric response in the calibration 
plot constructed with standard solutions. 
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3. Results and discussion 
The synthesis of V-Phe-SWCNT hybrids was accomplished by following the procedure 
described in the Experimental section according with the Scheme 1. Briefly, careful mono-
alkylation of viologen with 2-bromoethylamine in stoichiometric conditions afforded 1-(3-
aminoethyl)-4,4’-bipyridinium bromine; functionalization of SWCNT was based on well-
known aryl-diazonium chemistry in the presence of isoamyl nitrite [Palacin et al., 2009] 
followed by simple condensation reaction of the resulting HOOC-Phe-SWCNT with 1-(3-
aminoethyl)-4,4’-bipyridinium bromine. 
            
 
Scheme 1. Scheme showing the steps for the synthesis of V-Phe-SWCNTs. Reagents and 
conditions: (a) 4-aminobenzoic acid, isoamylnitrite, NMP, 70°C for 24h; (b) 1-(3-
aminoethyl)-4,4’-bipyridinium bromine, DCC, HOBt, at 60°C, 3 days; (c) 2-
bromoethylamine, DMF, 120°C, 24 h. 
a
COOH
b, c
N N
Br
NH2
+
CH
3
CN
reflux, 1.5 h
N N+
NH2
Br
NHO
N+
N+
NH2
Br
Br
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The V-Phe-SWCNT hybrids were characterized by using different spectroscopic techniques 
(FT-IR, Raman, UV-vis spectroscopies), TGA and Kaiser test. Details on this 
characterization are given in the Supplementary Material. 
The functionalization degree of SWCNT hybrids and the amount of groups anchored to the 
nanotubes were quantified by TGA. Samples were heated over a temperature range of 40 - 
1000 ºC at a scanning rate of 10ºC/min under nitrogen atmosphere. At 600°C, the 
thermogram shown in Figure S1 shows a weight loss of 10.3 % for pristine-SWCNT, 24.4 
% for HOOC-Phe-SWCNT and 43.6 % for V-Phe-SWCNT. The corrected weight loss due 
to the functional groups on CNTs was estimated to be 14 % for HOOC-Phe-SWCNT and 
33.3 % for V-Phe-SWCNT. Consequently, the number of phenyl acid functional groups in 
SWCNT was estimated as 1 per 50 carbon atoms, and with the same calculation, the 
number of viologen groups attached to the sidewall is approximately 1 per 114 carbon 
atoms. 
Raman spectra (Figure 1) of pristine-SWCNT showed the characteristics bands, a 
disorder mode (D-Band) with low intensity at 1292 cm
-1 
and a tangential mode (G-Band) at 
1595 cm
-1
(ID/IG =0.09). After functionalization, the intensity of the D-Band (ID/IG =0.54) 
increased (associated with the transformation of the sp
2
 to sp
3
 carbons), which indicated the 
incorporation of organic moiety on the surface of the CNT. Figure S2(A) shows the radial 
breathing mode of the CNT (RBM zone) before and after Tour reaction. The reduction of 
the tubes intensity also confirms the incorporation of the different species on the wall. 
Furthermore, the G
+
-Band is sensitive to charge transfer, as shown at Figure S2(B),  the G-
Band is up-shifted by 2 cm
-1
 in the V-Phe-SWCNT as compared to pristine-SWCNT due to 
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the p-doping [Straub et al., 2014] [Voggu et al., 2008]. This result confirmed that the 
electron-acceptor viologen was attached on the skeleton of SWCNT. 
 
 
Figure 1. Raman spectra (785 nm excitation) of pristine-SWCNT and V-Phe-SWCNT. The 
relative degree of functionalization was calculated by dividing the intensity of the D-Band 
by the G-Band. 
FT-IR spectroscopy provided important information about the covalent linkage of 
the viologen on the surface of SWCNT (Figure S3). Comparing with pristine-SWCNT, V-
Phe-SWCNT showed the characteristic bands of the skeletal in-plane vibrations of graphitic 
domains at 1554 cm
-1
, the aliphatic C-H stretching mode at 2919 cm
-1
and aromatic C-H 
nearby 3005 cm
-1
. Furthermore, the appearance of strong peaks attributed to the viologen 
units were clearly observed at 3450 cm
-1
 (2x N-H vibrations), and 1095 cm
-1
 (C-N bond). 
In addition, a new peak at 1642 cm
-1 
was observed which can be assigned to an amide 
carbonyl stretching mode indicating the chemical attachment of the viologen on the 
500 1000 1500 2000 2500 3000
0.0
0.2
0.4
0.6
0.8
1.0
G
2D
ID/IG = 0.54
In
te
n
s
it
y
Raman Shift / cm -1
pristine-SWCNT
V-Phe-SWCNT
D
ID/IG = 0.09
 15 
SWCNT wall. In agreement with Raman and FT-IR information, UV-vis spectra of the V-
Phe-SWCNT hybrid (Figure S4) revealed the presence of the viologen unit by the 
appearance of a peak at 382 nm conversely to that observed with the pristine-SWCNT. The 
presence of primary amine on the V-Phe-SWCNT hybrid was determined by using the 
Kaiser test [Tuci et al., 2012]. 
Preparation of the V-Phe-SWCNT(-HRP)-anti-TGF-TGF-β1-anti-TGF-Biotin-Strept/ 
SPCE immunosensor.  
The methodology employed for the preparation of the immunosensor involved the 
following steps: a) preparation of V-Phe-SWCNT(-HRP)-anti-TGF conjugates by covalent 
linkage of HRP and anti-TGF onto V-Phe-SWCNT hybrids; b) construction of the 
immunosensing platform by immobilizing biotinylated antibodies onto 4-carboxyphenyl-
functionalized SPCEs modified with covalently bonded streptavidin; c) implementation of 
a sandwich type immunoassay for TGF-β1 with signal amplification through the use of V-
Phe-SWCNT(-HRP)-anti-TGF conjugates  as carrier tags. The protocols used were 
described in the Experimental section, and Figure 2 shows schematically these steps and the 
reaction providing the electrochemical response. The proposed strategy took advantage of 
both the good performance of grafted electrochemical scaffolds for covalent immobilization 
of immunoreagents, and the amplification of the electrochemical responses with V-Phe-
SWCNT(-HRP)-anti-TGF conjugates. Modification of carbon electrodes through free 
radical grafting is known to provide compact and stable monolayers with specific 
functionalities. In the followed method, the electrochemical reduction of diazonium salt of 
4-ABA onto SPCEs was performed followed by streptavidin immobilization by means of 
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EDC/NHSS chemistry. The experimental conditions used in this step were those optimized 
previously [Moreno-Guzmán et al., 2012]. 
Regarding V-Phe-SWCNT(-HRP)-anti-TGF conjugates used as signals amplification tags, 
they were prepared by covalent immobilization of HRP and anti-TGF on the V-Phe-
SWCNTs. In order to attain the maximum number of biomolecules immobilized on the 
nanotubes conjugate, covalent attachment to carboxylic groups at HOOC-Phe-SWCNTs 
was performed after activation with EDC/NHSS system and, furthermore, terephthalic acid 
was used as carbonyl-terminated linker for covalently immobilization onto amino groups of 
viologen moiety [Rahim Ruslinda et al., 2013]. 
 
 
Figure 2. Schematic display of the different steps involved in the construction of an 
amperometric immunosensor for TGF-β1 using V-Phe-SWCNT hybrids 
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Characterization of V-Phe-SWCNT(-HRP)-anti-TGF by UV-vis and FT-IR spectroscopies 
was also made with the results showed in the Supplementary Material (Figure S5). 
Absorption spectra of V-Phe-SWCNT(-HRP)-anti-TGF shows the band at 266 nm 
corresponding to the presence of the antibody (see Figure S5A), which confirmed the 
successful formation of the hybrid. Regarding FT-IR spectrum of V-Phe-SWCNT-HRP-
anti-TGF (Figure S5B) it showed a broader band for the characteristic O-H bending 
vibration at 3429 cm
-1
, besides to new bands in the fingerprint region, which confirmed the 
antibody attachment, while the characteristic bands of V-SWCNT-Phe were maintained. In 
addition, V-Phe-SWCNT(-HRP)-anti-TGF displayed new bands at 803 cm
-1
, around 656 
cm
-1
 and 478 cm
-1
, which are associated with the bound of antibody. 
 
Figure 3 shows cyclic voltammograms recorded in the 0.0 to -0.8 V potential range (vs. Ag 
pseudo-reference electrode) at V-Phe-SWCNT/GCE (curves 1 and 3) and V-Phe-SWCNT-
HRP/GCE (curves 2 and 4) for solutions prepared in absence and in the presence of H2O2. 
As expected, the V-Phe-SWCNT-HRP/SPCE provided more sensitive response to the 
reduction of H2O2 which can be attributed to the role of V-Phe-SWCNT as mediator of the 
HRP catalytic reaction [Dong et al., 1997]. This behavior is in agreement with that reported 
by Jia
5
 for the electrochemical reduction of H2O2 at a glassy carbon electrode modified with 
gold nanoparticles-N,N′-bis(3-aminopropyl-4,4′-bipyridinium) tetrabromide (AuNPs/ 
BAPV/GCE) in the absence and in the presence of HRP. The following reaction scheme 
was suggested for the electrocatalytic process [Quan et al., 2010]. 
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Figure 3. Cyclic voltammograms recorded in 0.1 M phosphate buffer solution 
(voltammograms 1 and 2) containing 0.044 mM H2O2 (voltammograms 3 and 4) at: (1) V-
Phe-SWCNT/GCE (voltammograms 1 and 3) and V-Phe-SWCNT-HRP/GCE 
(voltammograms 2 and 4). 
 
According with the cyclic voltammograms, a detection potential of – 0.3 V was selected for 
the amperometric measurements of H2O2 reduction and the subsequent determination of 
TGF-β1. Although the cathodic current increases as the potential is more negative, the 
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above value was chosen to avoid potential interferences from electroactive substances 
present in real samples.  
The variables involved in the preparation of the immunosensor for TGF-β1 were optimized. 
The effect on the electrochemical responses of the following parameters were tested: a) the 
loadings of HRP and anti-TGF antibody onto V-Phe-SWCNT; b) the streptavidin loading 
onto SPCEs and c) the biotinylated antibody loading onto Strept-SPCEs. Other variables 
involved in the preparation of the modified electrodes such as the experimental conditions 
for grafting of SPCEs with 4-ABA diazonium salt or the amount of EDC/NHSS for 
covalent immobilization of biomolecules were optimized previously [Moreno-Guzmán et 
al., 2012]. Details on these optimization studies are provided in Supplementary Material 
and Figs. S6 and S7. 
 
Analytical characteristics of the immunosensor.   
Figure 4 shows the calibration plot for TGF-β1 constructed with the developed 
immunosensor under the optimized working conditions. Error bars were calculated from 
measurements carried out with three different immunosensors in each case. In addition, 
some typical recorded amperograms used for the construction of the calibration graph are 
also displayed.  The steady state current vs. logarithm of TGF-β1 concentration follows the 
adjusted equation i, nA = (332 ± 9) log [TGF-β1], pg mL-1 - (99 ± 18) (r2 = 0.996) with a 
range of linearity extending between 2.5 and 1000 pg mL
-1
 TGF-β1. This range covers 
almost three orders of magnitude and is adequate for the determination of the cytokine in 
clinical samples taking into account the expected concentrations, at ng mL
-1 
level, in plasma 
[Grainger et al., 2000]. The limit of detection, 0.95 pg mL
-1
, was calculated according to 
the 3sb criterion, where sb was estimated as the standard deviation, expressed in 
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concentration units, of 10 blank current measurements (0 ng mL
-1
 TGF-β1). These 
analytical characteristics improve notably those reported with other previous 
immunosensors. For example, the lowest concentration in the calibration plot, 2.5 pg mL
-1
, 
is six times lower and the limit of detection ten times lower than the corresponding values 
reported for immunosensors constructed using carboxylated magnetic beads [Sánchez-
Tirado et al., 2017]. Moreover, the immunosensor described in this work provides a 
calibration plot covering a wider linear range of concentrations (extending up to almost an 
order of magnitude larger) with a slope 60 times higher and a slightly lower limit of 
detection than the values achieved with an immunosensor prepared through click chemistry 
[Sánchez-Tirado et al., 2016]. The developed immunosensor also exhibits a LOD value 
remarkably smaller than those provided with the aptasensor (1 ng mL
-1
) [Matharu et al., 
2014] and the impedimetric immunosensor (0.570 ng mL
-1
) [Yao et al., 2016]. Most 
importantly, the analytical characteristics achieved with the proposed immunosensor also 
improve those claimed for the commercial ELISA kits. For example, Duo Sets ELISA 
Development System (DY240-05) from R&D Systems (www.rndsystems. 
com/products/human-tgf-beta-1-duoset-elisa_dy240) provides a calibration graph with a 
linear absorbance vs log [TGF-β1] ranging between 31 and 1000 pg mL-1, and requires an 
assay time of 5h 20 min which is remarkably longer than the time needed for preparing and 
using the developed electrochemical immunosensor (2h 30 min). In both cases, the assay 
time was counted since the capture antibody was immobilized. 
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Figure 4. Calibration plot (left) and amperograms recorded (right) for the amperometric 
determination of TGF-β1 with the V-Phe-SWCNT(-HRP)-anti-TGF-TGF-β1- anti-TGF-
Biotin-Strept/SPCE immunosensor; TGF-β1, μg mL-1: 5 (1); 7.5 (2); 10 (3); 25 (4); 50 (5); 
75 (6); 125 (7); 250 (8); 500 (9).  
 
The reproducibility of the amperometric responses obtained with different immunosensors 
was evaluated by preparing sets of immunosensors both on the same day and on different 
days using a new anti-TGF-Biotin-Strept/SPCE in each case. Relative standard deviation 
(RSD) values of 3.4 % and 3.1 % (n=5) were calculated for the assays performed on the 
same day in the absence and in the presence of 125 pg/mL TGF-β1, respectively. In 
addition, RSD values of 6.5 % and 7.2 % (n=5) were obtained, respectively, for the 
measurements made on different days. These results reveal the good level of precision 
achieved in the fabrication and functioning of the developed immunosensor. Moreover, the 
storage ability of anti-TGF-Biotin-Strept/SPCE conjugates was also tested. Different anti-
TGF-Biotin-Strept/SPCEs were prepared on the same day, stored under humidity 
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conditions at 4°C, and employed to prepare immunosensors to measure 125 pg mL
-1
 TGF- 
β1 on different days. The results obtained (not shown) indicated that the immunosensor 
responses remained within the control limits at ±3s, were s was the standard deviation of 
the measurements (n=10) carried out on the first working day, for at least 30 days (no 
longer storage times were tested) demonstrating the excellent stability of the anti-TGF-
Biotin-Strept/SPCE conjugates. In addition, the stability of V-Phe-SWCNT(-HRP)-anti-
TGF conjugates was also checked by measuring 125 pg mL
-1
 TGF- β1 on different days 
with immunosensors constructed with different V-Phe-SWCNT(-HRP)-anti-TGF 
conjugates prepared on the same day, and stored in phosphate buffer solution of pH 7.4, at 
8°C. The immunosensor responses remained within the control limits at ± 3 s for at least 14 
days. 
A great selectivity against other proteins was also found. Figure 5 displays the 
immunosensor amperometric responses in the absence and in the presence of 50 pg mL
-1
 
TGF-β1, and in the presence of 5 pg mL-1 adiponectin (APN), 50 ng mL-1 bovine serum 
albumin (BSA), 12 ng mL
-1
 cortisol, 50 ng mL
-1
 human immunoglobulin G (IgG), 50 pg 
mL
-1
 interleukin 1 beta (IL–1β), 50 pg mL-1  interleukin 6 (IL–6), 250 pg mL-1 interleukin 8 
(IL–8), and 10 pg mL-1 tumoral necrosis factor alpha (TNF–α). These concentrations are 
those expected according to the literature in healthy individuals. As it is clearly seen in 
Figure 5, no significant interference was apparent for any potential interfering biomolecule. 
Interestingly, the moderate detection potential used (-300 mV) prevents the interference 
from electroactive species usually present in biological samples such as ascorbic (AA) and 
uric (UA) acids. 
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Figure 5. Amperometric responses measured with V-Phe-SWCNT(-HRP)-anti-TGF-TGF-
β1-anti-TGF-Biotin-Strept/SPCE immunosensors for 0 (white) and 50 (grey) pg mL−1 
TGF-β1 standards in the absence and in the presence of 370 µg mL-1 ascorbic acid (AA), 5 
pg mL
−1
 adiponectin (APN), 50 ng mL
-1
 bovine serum albumin (BSA), 12 ng mL
−1
 cortisol, 
50 ng mL
-1
 immunoglobulin G (IgG), 50 pg mL
-1 
 interleukin 1 beta (IL-1β), 50 pg mL-1 
interleukin 6 (IL-6), 250 pg mL
-1
 interleukin 8 (IL-8), 10 pg mL
-1
 tumoral necrosis factor 
alpha (TNF-α) and 50 µg mL-1 uric acid (UA). 
 
Determination of TGF-β1 in saliva.  
The usefulness of the immunosensor for the determination of low TGF-β1 concentrations in 
real samples was evaluated by analyzing saliva following the procedure described in 
section 2.3.5. Saliva from four volunteers were analyzed. Firstly, the possible existence of 
matrix effects was tested by comparing the slopes value of the calibration plot constructed 
by successive addition of aliquots of TGF-β1 standards to the sample with that measured 
with the calibration graph prepared with analyte standard solutions. The application of the 
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Student t test provided texp values 0.969, 0.615, 0.254 and 0.221 lower than the tabulated 
one, ttab = 2.179 for α = 0.05 and n = 5. Therefore, the determination of TGF-β1 in saliva 
can be performed directly by interpolation of the amperometric current measured with the 
immunosensor for an aliquot of the undiluted sample, into the calibration plot constructed 
with standard solutions. The concentrations found in the analysis of the real samples (for 
two smoker and two non-smoker individuals) were compared with the results provided with 
a commercial ELISA kit (Table 1). As it can be seen, there is an excellent agreement 
between the results obtained by both methods. TGF-β1 concentration values of 24 pg mL-1 
and 25 pg mL
-1
 TGF-β1 have been reported in the literature in saliva of healthy individuals 
[Yousefzadeh et al., 2006] [Brand et al., 2014]. Therefore, the values calculated with the 
immunosensor are also in good agreement with reported data. All these results 
demonstrated the usefulness of the developed immunosensor for the analysis of TGF-β1at 
low concentration levels in saliva with minimal sample treatment. 
Table 1. Determination of TGF-β1 in real saliva samples 
TGF–β1 
Saliva 
Immunosensor (n = 5), pg/mL ELISA (n = 4), pg/mL 
smoker 27.6 ± 0.2 27.3 ± 0.2 
smoker 26.4 ± 0.5 26.3 ± 0.1 
non-smoker 21.2 ± 0.6 21.2 ± 0.1 
non-smoker 22.8 ± 0.3 22.7 ± 0.5 
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4. Conclusions 
Viologen-SWCNTs hybrids, prepared using a novel method by aryl-diazonium chemistry 
in the presence of isoamylnitrite followed by condensation of the resulting HOOC-Phe-
SWCNT with 1-(3-aminoethyl)-4,4’-bipyridinium bromine and N-alkylation with 2-
bromoethylamine, have been used as carrier tags for signal amplification in the construction 
of an amperometric immunosensor for TGF-β1. The implementation of a sandwich type 
immunoassay allowed improved analytical characteristic to be obtained in terms of wider 
linear dynamic range of response and lower detection limit than those reported with other 
previous immunosensors and those claimed for ELISA kits. In addition, a great selectivity 
against other proteins and ascorbic and uric acid was also found. The developed 
immunosensor was applied to the determination of TGF-β1 in saliva samples with minimal 
sample treatment and with results in excellent agreement with those obtained by using a 
commercial ELISA kit. 
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Highlights 
 Synthesis of viologen-SWCNT hybrids by aryl-diazonium chemistry. 
 Preparation of TGF-β1 immunosensor by grafting with 4-carboxyphenyl onto 
screen-printed carbon electrodes. 
 Signal amplification using V-Phe-SWCNT(-HRP)-anti-TGF as carrier nanotags. 
 Application to real saliva samples. 
 
 
